135 related articles for article (PubMed ID: 1466808)
1. Conformational effects of selected cancer-related amino acid substitutions in the p53 protein.
Brandt-Rauf PW; De Vivo I; Dykes DC; Pincus MR
J Biomol Struct Dyn; 1992 Oct; 10(2):253-64. PubMed ID: 1466808
[TBL] [Abstract][Full Text] [Related]
2. Conformational effects of environmentally induced, cancer-related mutations in the p53 protein.
Brandt-Rauf PW; Monaco R; Pincus MR
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9262-6. PubMed ID: 7937752
[TBL] [Abstract][Full Text] [Related]
3. Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein.
Legros Y; Meyer A; Ory K; Soussi T
Oncogene; 1994 Dec; 9(12):3689-94. PubMed ID: 7526318
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
5. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region.
Srinivasan R; Maxwell SA
Oncogene; 1996 Jan; 12(1):193-200. PubMed ID: 8552392
[TBL] [Abstract][Full Text] [Related]
6. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.
Vojtesek B; Dolezalova H; Lauerova L; Svitakova M; Havlis P; Kovarik J; Midgley CA; Lane DP
Oncogene; 1995 Jan; 10(2):389-93. PubMed ID: 7530828
[TBL] [Abstract][Full Text] [Related]
7. Temperature-sensitive mutants of p53 associated with human carcinoma of the lung.
Medcalf EA; Takahashi T; Chiba I; Minna J; Milner J
Oncogene; 1992 Jan; 7(1):71-6. PubMed ID: 1741167
[TBL] [Abstract][Full Text] [Related]
8. The effect of mutations on peptide models of the DNA binding helix of p53: evidence for a correlation between structure and tumorigenesis.
Trulson JA; Millhauser GL
Biopolymers; 1999 Mar; 49(3):215-24. PubMed ID: 9990839
[TBL] [Abstract][Full Text] [Related]
9. p53 mutants without a functional tetramerisation domain are not oncogenic.
Chène P; Bechter E
J Mol Biol; 1999 Mar; 286(5):1269-74. PubMed ID: 10064694
[TBL] [Abstract][Full Text] [Related]
10. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
11. Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.
Stavridi ES; Chehab NH; Caruso LC; Halazonetis TD
Protein Sci; 1999 Sep; 8(9):1773-9. PubMed ID: 10493578
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.
Sigal A; Rotter V
Cancer Res; 2000 Dec; 60(24):6788-93. PubMed ID: 11156366
[TBL] [Abstract][Full Text] [Related]
13. A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53.
Hainaut P; Milner J
Cancer Res; 1993 Apr; 53(8):1739-42. PubMed ID: 8467489
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.
Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR
Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522
[TBL] [Abstract][Full Text] [Related]
15. Specific DNA binding by different classes of human p53 mutants.
Rolley N; Butcher S; Milner J
Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
Selivanova G; Wiman KG
Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
[TBL] [Abstract][Full Text] [Related]
17. Sequence-specific interaction of a conformational domain of p53 with DNA.
Srinivasan R; Roth JA; Maxwell SA
Cancer Res; 1993 Nov; 53(22):5361-4. PubMed ID: 8221671
[TBL] [Abstract][Full Text] [Related]
18. [P53 at the atomic scale: the multiple faces of a crystal].
Hainaut P
Bull Cancer; 1997 Jul; 84(7):747-51. PubMed ID: 9339202
[TBL] [Abstract][Full Text] [Related]
19. The impact of p53 protein core domain structural alteration on ovarian cancer survival.
Rose SL; Robertson AD; Goodheart MJ; Smith BJ; DeYoung BR; Buller RE
Clin Cancer Res; 2003 Sep; 9(11):4139-44. PubMed ID: 14519637
[TBL] [Abstract][Full Text] [Related]
20. [Relevance of p53 protein and its mutations for novel strategies in cancer therapy].
Müller P; Nenutil R; Vojtĕsek B
Cas Lek Cesk; 2004; 143(5):313-7. PubMed ID: 15305766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
